Amerge (naratriptan) for migraines

Glaxo is now marketing Amerge (naratriptan) for migraines.It's a new oral "triptan"...similar to Imitrex (sumatriptan).

The big difference is that Amerge is longer-acting because ithas a longer half-life.

This means that recurrent headaches are less likely withAmerge than with Imitrex. About 40% of patients using Imitrex haverecurrent headaches because of its short half-life.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote